Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nutrients ; 9(11)2017 Oct 27.
Artigo em Inglês | MEDLINE | ID: mdl-29077030

RESUMO

The chemopreventive and anticancer effects of resveratrol (RSV) are widely reported in the literature. Specifically, mechanisms involving epigenetic regulation are promising targets to regulate tumor development. Bromodomains act as epigenetic readers by recognizing lysine acetylation on histone tails and boosting gene expression in order to regulate tissue-specific transcription. In this work, we showed that RSV is a pan-BET inhibitor. Using Differential Scanning Fluorimetry (DSF), we showed that RSV at 100 µM increased the melting temperature (∆Tm) of BET bromodomains by around 2.0 °C. The micromolar dissociation constant (Kd) range was characterized using Isothermal Titration Calorimetry (ITC). The RSV Kd value accounted to 6.6 µM in case of BRD4(1). Molecular docking proposed the binding mode of RSV against BRD4(1) mimicking the acetyl-lysine interactions. All these results suggest that RSV can also recognize epigenetic readers domains by interacting with BET bromodomains.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Dieta , Epigênese Genética , Lisina/metabolismo , Proteínas Nucleares/metabolismo , Proteínas/antagonistas & inibidores , Estilbenos/farmacologia , Fatores de Transcrição/metabolismo , Acetilação , Proteínas de Ciclo Celular , Expressão Gênica/efeitos dos fármacos , Histonas/metabolismo , Humanos , Cinética , Simulação de Acoplamento Molecular , Neoplasias/metabolismo , Fitoterapia , Extratos Vegetais/farmacologia , Resveratrol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA